• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 感染小鼠的 T 细胞反应的定位和作用。

Mapping and role of T cell response in SARS-CoV-2-infected mice.

机构信息

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Guangzhou Customs District Technology Center, Guangzhou, China.

出版信息

J Exp Med. 2021 Apr 5;218(4). doi: 10.1084/jem.20202187.

DOI:10.1084/jem.20202187
PMID:33464307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7814348/
Abstract

Virus-specific T cells play essential roles in protection against multiple virus infections, including SARS-CoV and MERS-CoV. While SARS-CoV-2-specific T cells have been identified in COVID-19 patients, their role in the protection of SARS-CoV-2-infected mice is not established. Here, using mice sensitized for infection with SARS-CoV-2 by transduction with an adenovirus expressing the human receptor (Ad5-hACE2), we identified SARS-CoV-2-specific T cell epitopes recognized by CD4+ and CD8+ T cells in BALB/c and C57BL/6 mice. Virus-specific T cells were polyfunctional and were able to lyse target cells in vivo. Further, type I interferon pathway was proved to be critical for generating optimal antiviral T cell responses after SARS-CoV-2 infection. T cell vaccination alone partially protected SARS-CoV-2-infected mice from severe disease. In addition, the results demonstrated cross-reactive T cell responses between SARS-CoV and SARS-CoV-2, but not MERS-CoV, in mice. Understanding the role of the T cell response will guide immunopathogenesis studies of COVID-19 and vaccine design and validation.

摘要

病毒特异性 T 细胞在预防多种病毒感染中发挥着重要作用,包括严重急性呼吸综合征冠状病毒(SARS-CoV)和中东呼吸综合征冠状病毒(MERS-CoV)。虽然在 COVID-19 患者中已经鉴定出了针对 SARS-CoV-2 的 T 细胞,但它们在保护感染 SARS-CoV-2 的小鼠中的作用尚未确定。在这里,我们使用通过表达人受体的腺病毒(Ad5-hACE2)转导使小鼠对 SARS-CoV-2 感染敏感的方法,鉴定了 BALB/c 和 C57BL/6 小鼠中 CD4+和 CD8+T 细胞识别的 SARS-CoV-2 特异性 T 细胞表位。病毒特异性 T 细胞具有多功能性,能够在体内裂解靶细胞。此外,研究证明Ⅰ型干扰素途径对于 SARS-CoV-2 感染后产生最佳抗病毒 T 细胞反应至关重要。单独的 T 细胞疫苗接种可部分保护 SARS-CoV-2 感染的小鼠免受严重疾病的侵害。此外,结果表明,在小鼠中,SARS-CoV 和 SARS-CoV-2 之间存在交叉反应性 T 细胞反应,但与 MERS-CoV 没有交叉反应性。了解 T 细胞反应的作用将指导 COVID-19 的免疫发病机制研究以及疫苗的设计和验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/68e13b340d51/JEM_20202187_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/4eecde25583e/JEM_20202187_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/8e904580acb6/JEM_20202187_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/10552f1d2c22/JEM_20202187_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/e7ecc4e76f3e/JEM_20202187_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/0a917aa379bc/JEM_20202187_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/e27d966b3e6d/JEM_20202187_FigS4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/f3956e615bd1/JEM_20202187_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/8ae0a2dfbac2/JEM_20202187_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/7bccd503e27b/JEM_20202187_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/6dddbd357eb3/JEM_20202187_FigS5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/68e13b340d51/JEM_20202187_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/4eecde25583e/JEM_20202187_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/8e904580acb6/JEM_20202187_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/10552f1d2c22/JEM_20202187_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/e7ecc4e76f3e/JEM_20202187_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/0a917aa379bc/JEM_20202187_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/e27d966b3e6d/JEM_20202187_FigS4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/f3956e615bd1/JEM_20202187_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/8ae0a2dfbac2/JEM_20202187_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/7bccd503e27b/JEM_20202187_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/6dddbd357eb3/JEM_20202187_FigS5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47f/7814348/68e13b340d51/JEM_20202187_Fig6.jpg

相似文献

1
Mapping and role of T cell response in SARS-CoV-2-infected mice.SARS-CoV-2 感染小鼠的 T 细胞反应的定位和作用。
J Exp Med. 2021 Apr 5;218(4). doi: 10.1084/jem.20202187.
2
mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2.mRNA 诱导的人血管紧张素转换酶 2 在小鼠中的表达,用于研究对严重急性呼吸综合征冠状病毒 2 的适应性免疫反应。
PLoS Pathog. 2020 Dec 16;16(12):e1009163. doi: 10.1371/journal.ppat.1009163. eCollection 2020 Dec.
3
Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.病毒特异性记忆 CD8 T 细胞为严重急性呼吸综合征冠状病毒致死性感染提供了实质性保护。
J Virol. 2014 Oct;88(19):11034-44. doi: 10.1128/JVI.01505-14. Epub 2014 Jul 23.
4
Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.在密码子优化的严重急性呼吸综合征相关冠状病毒刺突蛋白中鉴定小鼠CD8 T细胞表位
Virology. 2005 Apr 25;335(1):34-45. doi: 10.1016/j.virol.2005.01.050.
5
Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.用严重急性呼吸综合征冠状病毒(SARS CoV)S基因DNA进行初次免疫,并使用针对CD4+和CD8+T细胞的SARS CoV S表位进行加强免疫,可促进细胞免疫反应。
Vaccine. 2007 Sep 28;25(39-40):6981-91. doi: 10.1016/j.vaccine.2007.06.047. Epub 2007 Jul 16.
6
CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.CD8+ T 细胞对痘苗病毒 MVA 递送的中东呼吸综合征冠状病毒核衣壳蛋白的反应。
Viruses. 2018 Dec 16;10(12):718. doi: 10.3390/v10120718.
7
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV.严重急性呼吸综合征冠状病毒的T细胞免疫:对中东呼吸综合征冠状病毒疫苗研发的启示。
Antiviral Res. 2017 Jan;137:82-92. doi: 10.1016/j.antiviral.2016.11.006. Epub 2016 Nov 11.
8
Limited Recognition of Highly Conserved Regions of SARS-CoV-2.有限识别 SARS-CoV-2 的高度保守区域。
Microbiol Spectr. 2022 Feb 23;10(1):e0278021. doi: 10.1128/spectrum.02780-21.
9
Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses.前沿:小鼠 SARS-CoV-2 表位揭示了感染和疫苗诱导的 CD8+T 细胞反应。
J Immunol. 2021 Mar 1;206(5):931-935. doi: 10.4049/jimmunol.2001400. Epub 2021 Jan 13.
10
Genome-Wide B Cell, CD4, and CD8 T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines.从 SARS-CoV-2 中鉴定出高度保守的人类和动物冠状病毒的全基因组 B 细胞、CD4 和 CD8 T 细胞表位,作为预防性泛冠状病毒疫苗的靶点。
J Immunol. 2021 Jun 1;206(11):2566-2582. doi: 10.4049/jimmunol.2001438. Epub 2021 Apr 28.

引用本文的文献

1
Upper respiratory tract immunization with PamCys-adjuvanted spike protein vaccine achieves sterilizing protection against SARS-CoV-2.用PamCys佐剂刺突蛋白疫苗进行上呼吸道免疫可实现对SARS-CoV-2的灭菌保护。
Front Immunol. 2025 Sep 2;16:1654126. doi: 10.3389/fimmu.2025.1654126. eCollection 2025.
2
Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine.辅助组合和抗原多聚化塑造了针对严重急性呼吸综合征冠状病毒2受体结合域亚单位疫苗的中和抗体和T细胞反应。
Front Immunol. 2025 Jul 17;16:1610422. doi: 10.3389/fimmu.2025.1610422. eCollection 2025.
3

本文引用的文献

1
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.无症状或轻症 COVID-19 康复者体内具有强大的 T 细胞免疫。
Cell. 2020 Oct 1;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017. Epub 2020 Aug 14.
2
Broad and strong memory CD4 and CD8 T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.在 COVID-19 之后,英国康复个体中 SARS-CoV-2 诱导产生的广泛而强大的记忆性 CD4 和 CD8 T 细胞。
Nat Immunol. 2020 Nov;21(11):1336-1345. doi: 10.1038/s41590-020-0782-6. Epub 2020 Sep 4.
3
Commentary: SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.
Exposure to COVID-19 virus-like particles modulates firing patterns of cortical neurons in the mouse brain.
暴露于新冠病毒样颗粒会调节小鼠大脑皮层神经元的放电模式。
Commun Biol. 2025 Jul 3;8(1):993. doi: 10.1038/s42003-025-08435-8.
4
Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial.在一项安慰剂对照疗效试验中,疫苗诱导的T细胞反应与降低严重COVID-19风险相关。
EBioMedicine. 2025 Jul;117:105809. doi: 10.1016/j.ebiom.2025.105809. Epub 2025 Jun 14.
5
Development of a peptide-based vaccine using a T cell epitope derived from SARS-CoV-2.利用源自严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的T细胞表位开发基于肽的疫苗。
iScience. 2025 Apr 28;28(6):112542. doi: 10.1016/j.isci.2025.112542. eCollection 2025 Jun 20.
6
Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice.人类和ACE2人源化小鼠对SARS-CoV-2感染的免疫反应。
Fundam Res. 2021 Mar;1(2):124-130. doi: 10.1016/j.fmre.2021.03.001. Epub 2021 Mar 3.
7
An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.一种RBD-Fc黏膜疫苗为小鼠和仓鼠提供了针对SARS-CoV-2的变异体抗性保护。
NPJ Vaccines. 2025 May 18;10(1):100. doi: 10.1038/s41541-025-01155-4.
8
An adjuvanted chimeric spike antigen boosts lung-resident memory T-cells and induces pan-sarbecovirus protective immunity.一种佐剂化嵌合刺突抗原可增强肺驻留记忆T细胞并诱导泛沙贝病毒保护性免疫。
NPJ Vaccines. 2025 May 8;10(1):89. doi: 10.1038/s41541-025-01144-7.
9
Simian Immunodeficiency Virus-Based Virus-like Particles Are an Efficient Tool to Induce Persistent Anti-SARS-CoV-2 Spike Neutralizing Antibodies and Specific T Cells in Mice.基于猿猴免疫缺陷病毒的病毒样颗粒是在小鼠中诱导持久性抗SARS-CoV-2刺突中和抗体和特异性T细胞的有效工具。
Vaccines (Basel). 2025 Feb 21;13(3):216. doi: 10.3390/vaccines13030216.
10
Vaccination with Plasmids Encoding the Fusion Proteins D-S1, D-S1N and O-SN from SARS-CoV-2 Induces an Effective Humoral and Cellular Immune Response in Mice.用编码来自严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的融合蛋白D-S1、D-S1N和O-SN的质粒进行疫苗接种可在小鼠中诱导有效的体液免疫和细胞免疫反应。
Vaccines (Basel). 2025 Jan 28;13(2):134. doi: 10.3390/vaccines13020134.
评论:中国武汉一家三级甲等医院中癌症患者的新冠病毒传播情况
Front Oncol. 2020 Jul 10;10:1223. doi: 10.3389/fonc.2020.01223. eCollection 2020.
4
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.未暴露于 SARS-CoV-2 人群中的选择性和交叉反应性 T 细胞表位。
Science. 2020 Oct 2;370(6512):89-94. doi: 10.1126/science.abd3871. Epub 2020 Aug 4.
5
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.SARS-CoV-2 反应性 T 细胞在健康供体和 COVID-19 患者中的研究。
Nature. 2020 Nov;587(7833):270-274. doi: 10.1038/s41586-020-2598-9. Epub 2020 Jul 29.
6
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的生物学、临床和流行病学特征,以及 ACE2 的 AutoDock 模拟
Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6.
7
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.COVID-19 和 SARS 病例以及未感染对照者的 SARS-CoV-2 特异性 T 细胞免疫。
Nature. 2020 Aug;584(7821):457-462. doi: 10.1038/s41586-020-2550-z. Epub 2020 Jul 15.
8
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.生成一种广泛适用于 COVID-19 发病机制、疫苗接种和治疗的模型。
Cell. 2020 Aug 6;182(3):734-743.e5. doi: 10.1016/j.cell.2020.06.010. Epub 2020 Jun 10.
9
Kinetics of viral load and antibody response in relation to COVID-19 severity.病毒载量和抗体反应动力学与 COVID-19 严重程度的关系。
J Clin Invest. 2020 Oct 1;130(10):5235-5244. doi: 10.1172/JCI138759.
10
Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.急性呼吸窘迫综合征的 COVID-19 患者中 SARS-CoV-2 特异性 T 细胞的表型和动力学。
Sci Immunol. 2020 Jun 26;5(48). doi: 10.1126/sciimmunol.abd2071.